Nat Med 31 , 951962 (2025)
Ozempic and Rybelsus are two other brands of semaglutide on the market that are approved by the FDA for glycemic control in diabetes but not for weight management
Ozempic Lawsuit Timeline & News July 2026 July 1, 2026: MDL Over Alleged Ozempic, GLP-1 Side Effects Continues To Grow The federal GLP-1 MDL, which accuses the manufacturers of drugs like Ozempic of failing to warn patients of potential side effects, continues to add cases
New Zealand health survey: annual data explorer
You cant really talk about one without the other. As GLP-1 use continues to rise nationwide, Skaff sees both promise and caution
The Institute for Clinical and Economic Review (ICER) found that among 11 large payers covering 57M lives, only ~70% of their GLP-1 policies met fair access criteria